Alliance launches with 26 founding companies to develop a national strategy for U.S. biotechnology leadershipBOCA RATON, Fla., May 13, 2026 ...

Company rapidly advancing Phase 3 programs designed to deliver best-in-class efficacy with convenient quarterly dosing in ...

KOMZIFTI (ziftomenib) net product revenue in first full quarter of commercialization - - Robust new patient starts and early launch dynamics, including repeat use, switching and combination ...

Virtual Investor Event Kura will host a webcast and conference call on June 3, 2026, at 8:00 am ET / 5:00 am PT, featuring management and a clinical investigator from the KOMET-007 study. The live ...

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced two presentations from the company’s ...

Scientists at UCSF have discovered a new human cell, DSC4, found only in the initial weeks of pregnancy. This cell might ...

FUJIFILM Biosciences, a global leader in the life science market, and NextCell Pharma AB, a clinical-stage company ...

Tumors do not communicate only with immune cells, blood vessels, and stromal tissue. A growing body of evidence suggests that cancer can also co-opt the nervous system, reshaping the tumor ...

Microfluidic architecture with vascular and tumor chambers recreates perfusion and desmoplastic stroma, enabling longitudinal visualization of PDAC cell–stromal dynamics under near-physiologic flow.

Learn about superficial spreading melanoma, from the ABCDE diagnostic rules to the latest in immunotherapy, targeted care and surgical options. Superficial spreading ...

Zirconia is widely regarded as a promising alternative to titanium for bone and dental implants because of its aesthetic ...

Tumors do not communicate only with immune cells, blood vessels, and stromal tissue. A growing body of evidence suggests that ...